Latest Breaking News On - Be treated with the company potentially - Page 1 : vimarsana.com

DGAP-News: Immunic, Inc. / Key word(s): Study Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935 27.10.2021 / 12:30 The issuer is solely

New zealandEdna kaplanHella kohlhofPaula schwartzJessica breuDaniel vittExchange commissionBe treated with the company potentiallyRx communications groupImmunic incDistribution servicesAnnounces first psoriasis patient enrolledOngoing phasePotentially best in classInverse agonistPsoriasis area